Alto Neuroscience, Inc. (ANRO)
NYSE: ANRO · Real-Time Price · USD
24.47
+0.20 (0.82%)
At close: Apr 28, 2026, 4:00 PM EDT
24.47
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:00 PM EDT
Alto Neuroscience Employees
Alto Neuroscience had 68 employees as of December 31, 2025. The number of employees decreased by 8 or -10.53% compared to the previous year.
Employees
68
Change (1Y)
-8
Growth (1Y)
-10.53%
Revenue / Employee
n/a
Profits / Employee
-$929,971
Market Cap
854.94M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 68 | -8 | -10.53% |
| Dec 31, 2024 | 76 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| MannKind | 592 |
| MeiraGTx Holdings | 403 |
| Kura Oncology | 260 |
| ARS Pharmaceuticals | 163 |
| Sana Biotechnology | 142 |
| Theravance Biopharma | 90 |
| Crescent Biopharma | 44 |
| Compass Therapeutics | 39 |
ANRO News
- 7 days ago - Alto Neuroscience Initiates Phase 2b Trial of ALTO-207 in Treatment-Resistant Depression - Business Wire
- 26 days ago - Alto Neuroscience Reports Topline Data from Phase 2 Proof-of-Concept Study of ALTO-101 and Highlights Pipeline Advancements - Business Wire
- 6 weeks ago - Alto Neuroscience Transcript: Stifel 2026 Virtual CNS Forum - Transcripts
- 6 weeks ago - Alto Neuroscience Announces $120 Million Private Placement Financing - Business Wire
- 6 weeks ago - Alto Neuroscience Reports Full Year 2025 Financial Results and Recent Business Highlights - Business Wire
- 6 weeks ago - Alto Neuroscience Announces Participation at the Stifel 2026 Virtual CNS Forum - Business Wire
- 2 months ago - Alto Neuroscience Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts
- 2 months ago - Alto Neuroscience Announces Participation in Upcoming Investor Conferences - Business Wire